Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06051539 · ClinicalTrials.gov registry record · NA
Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation
A NA study of Chronic Stroke, sponsored by MedRhythms.
- Active
- Registry status
- NA
- Development phase
- 234
- Enrollment target
- 1
- Study location
NCT06051539: Active NA study of Chronic Stroke, sponsored by MedRhythms.
NCT06051539 is a NA study of Chronic Stroke that is active but no longer recruiting, run by MedRhythms. The registered enrollment target is 234 participants, above the 32-participant average among 20 other Chronic Stroke trials with a reported enrollment target (631% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06051539, a NA study of Chronic Stroke, is active but no longer recruiting, sponsored by MedRhythms.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.
Primary Outcome
The purpose of this study is to assess engagement with MR-001 walking therapy in chronic stroke patients with a gait deficit in a real world setting. Engagement will be measured as number of walking sessions observed across the 12 week intervention period.
Conditions Studied
Interventions
- DEVICE MR-001
Study Locations (1)
Maine
- Curavit Clinical Research - DECENTRALIZED CLINICAL TRIAL - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT06051539 still lists
NCT06051539 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, above the 32-participant average among 20 other Chronic Stroke trials with a reported enrollment target (631% higher).
The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which MR-001 is the first listed.
NCT06051539 reports a single indexed study location in Maine.
Frequently Asked Questions
What is clinical trial NCT06051539 about?
NCT06051539 is a clinical study titled "Outcomes and Health Economics of Stroke Using Rhythmic Auditory Stimulation". The purpose of this trial is to assess engagement, efficacy, durability, and impact on health care resource utilization of MR-001 in persons with chronic stroke who have a gait deficit after in-home/community use.
What is the current status of trial NCT06051539?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2023-10-10. Estimated completion is 2025-12.
What conditions does trial NCT06051539 study?
This clinical trial studies the following conditions: Chronic Stroke.
What interventions are being tested in trial NCT06051539?
The interventions under investigation include: MR-001 (DEVICE).
Who is sponsoring clinical trial NCT06051539?
This trial is sponsored by MedRhythms, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06051539 being conducted?
This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06051539's enrollment target sits among peer trials
234 1st of 20 higher than 20 of 20 other Chronic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
Effect of NMES on Balance and Fall Risk in Chronic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation Mechanisms
RECRUITING · NA
-
Home-based FES Training in People With Chronic Stroke
RECRUITING · NA
-
Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI